
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
RRBP1 CRISPR/Cas9 KO Plasmid (h) | sc-410995 | 20 µg | $397.00 |
RRBP1 (ribosome binding protein 1) encodes an endoplasmic reticulum (ER) membrane–associated protein that supports co-translational targeting of nascent polypeptides to the ER and contributes to ER organization and secretory pathway capacity. By linking ribosomes to the rough ER, RRBP1 influences protein synthesis, folding, and trafficking, processes tightly connected to ER homeostasis and the unfolded protein response. Altered RRBP1 expression has been reported in contexts of cellular stress and proliferative remodeling, making it relevant for studying proteostasis, ER-associated adaptation, and signaling networks coupled to secretory demand. RRBP1 is therefore of interest in models examining ER stress sensitivity, membrane trafficking dynamics, and disease-associated perturbations of protein handling.
RRBP1 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the RRBP1 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the RRBP1 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the RRBP1 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish RRBP1 protein expression.
This CRISPR knockout system enables efficient generation of RRBP1-deficient cell models for investigation of RRBP1 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.